MR TAYLOR COFFEY
Taylor started his PhD with the University of Aberdeen in October of 2019. He comes to us from Chicago in the United States where he had worked for a number of years as a clinical research project coordinator at Northwestern University. He earned his Master's Degree in psychology and neuroscience from King's College London and is now interested in utilizing his psychology and clinical trial management background to improve clinical trial recruitment and retention through behavioural interventions.
Taylor's research interests primarily lie with how theoretical/behavioural approaches can be used in the context of improvement to clinical trials.
Applied Health Sciences
Taylor is currently working with Drs. Katie Gillies, Eilidh Duncan, and Heather Morgan on better understanding how theoretical approaches have been applied to clinical trial recruitment and retention and how we might design new approaches to surmount issues in these areas.
Taylor has undertaken a systematic mapping review (protocol available here: Mapping_Review_Protocol_Final.docx)to identify instances of behavioural theory being applied to aspects of recruitment or retention to clinical trials. The results of this review have informed the design of his original project, "Trial Recruiter Approaches to Communication of RETention At INformed consent" (TRAC-RETAIN). This project aims to address a general gap within trial methods research by contributing to research on retention, as well as research done with trial staff rather than participants. Staff involved in recruiting to trials will be probed for views and experiences regarding how they communicate information about retention to potential participants. This will be done primarily through qualitative interviews designed to illicit barriers and facilitators to a target behaviour, in this case, the communication of retention information. The barriers and facilitators identified are then analysed for behavioural components that are amenable to change through behaviour change techniques (BCTs). BCTs are the "smallest active ingredient" when attempting to change behaviours and are aligned to specific barriers to behaviour. These BCTs can be packaged into interventions aimed at delivering them to target groups to change the target behaviour. TRAC-RETAIN will design such interventions to address challenges in retaining participants to trials that are attributable to the behaviours of trial recruiters in their informed consent discussions. The interventions will be developed with the assistance of trial recruiters and members of the public to address these barriers effectively whilst respecting the autonomy of these stakeholders.
Funding and Grants
ISSF Patient and Public Involvement Fund
Start Date: 01/04/2021
End date: 31/08/2022